Emerging Issues on COVID-19 Vaccines: Allergies, Anaphylaxis and Low Dead Volume Syringes
Organization: Public Health Agency of Canada (PHAC)Published: 2021
"This moderated webinar is for health care providers who are administering COVID-19 vaccines. It describes allergy-related contraindications or precautions to COVID-19 vaccination and the features and management of anaphylaxis following administration of COVID-19 vaccines." - Emerging Issues on COVID-19 Vaccines: Allergies, Anaphylaxis and Low Dead Volume Syringes
Resource Group:
Implementation Tool
Product Type: Webinar
Vaccine Safety and Development
Program Delivery and Evaluation
Vaccine Management
Vaccine Safety
Clinics
Storage and Handling
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Webinar
Category:
Program Planning and Delivery,Vaccine Safety and Development,Program Delivery and Evaluation,Vaccine Management,Vaccine Safety,Clinics,Storage and Handling,Vaccine Safety,Adverse Events Following Immunization (AEFI),Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryVaccine Safety and Development
Program Delivery and Evaluation
Vaccine Management
Vaccine Safety
Clinics
Storage and Handling
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Population: Children (All)
Adolescents
High Risk Children
Adults
Pregnant and Breastfeeding People
High Risk Adults
Seniors
Region: National
Population: Children (All)
Adolescents
High Risk Children
Adults
Pregnant and Breastfeeding People
High Risk Adults
Seniors
Region: National
Language:
English
PDF
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.